Growth Metrics

Incyte (INCY) Cash & Equivalents (2016 - 2025)

Incyte (INCY) has disclosed Cash & Equivalents for 16 consecutive years, with $3.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 83.54% year-over-year to $3.1 billion, compared with a TTM value of $3.1 billion through Dec 2025, up 83.54%, and an annual FY2025 reading of $3.1 billion, up 83.54% over the prior year.
  • Cash & Equivalents was $3.1 billion for Q4 2025 at Incyte, up from $2.5 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.3 billion in Q1 2024 and bottomed at $987.3 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $2.4 billion, with a median of $2.3 billion recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 68.47% in 2024, then soared 98.01% in 2025.
  • Year by year, Cash & Equivalents stood at $2.1 billion in 2021, then surged by 43.45% to $3.0 billion in 2022, then rose by 8.88% to $3.2 billion in 2023, then crashed by 47.47% to $1.7 billion in 2024, then soared by 83.54% to $3.1 billion in 2025.
  • Business Quant data shows Cash & Equivalents for INCY at $3.1 billion in Q4 2025, $2.5 billion in Q3 2025, and $2.0 billion in Q2 2025.